Should you buy Eli Lilly or Novo Nordisk?
2030 Valuation Model, Eli Lilly vs Novo Nordisk!
Yesterday, I published the Eli Lilly vs Novo Nordisk report, where I analyzed why the stock price returns of both companies have diverged so much in the past year.
Today, I am presenting the 2030 Valuation Models for both companies.
As investors, we shouldn’t care about past performance as it is not indicative of future returns. We should focus on the future when making investment decisions.
In this report, I will create a valuation model for both companies using assumptions that I find realistic and achievable. Next, I will then compare the two valuation models to assess which company could be the better investment.
1. Novo Nordisk 2030 Valuation Model
2. Eli Lilly 2030 Valuation Model
3. Comparison
4. Conclusion
